摘要
目的:探讨甲泼尼龙联合生长抑素治疗急性胰腺炎的疗效。方法:将94例急性胰腺炎患者随机分成观察组47例(甲泼尼龙联合生长抑素治疗)和对照组47例(生长抑素治疗),对比两组的疗效。结果:两组在治疗效果、并发症发生率以及排气恢复、腹痛消失、尿淀粉酶恢复、血淀粉酶恢复、腹水消失等指标相比差异均具有统计学意义(P<0.05)。结论:甲泼尼龙联合生长抑素治疗重症急性胰腺炎治疗效果好,明显改善患者预后,提高患者生命质量。
Objective：To explore the therapeutic effect of Methyl prednisolone combined with somatostatin in the treatment of acute pancreatitis in clinical situation. Methods：94 cases of acute pancreatitis admitted from June 2013 to December 2015 were randomly divided into the observation group（ n = 47） and the control group（ n = 47）,with the treatment of prednisolone combined with somatostatin given in the former group and somatostatin alone in the latter group. The curative effect of the two groups was compared. Results： There were significant differences in therapeutic effect,complication incidence rates,exhaust recovery time,abdominal pain disappearance time,urine amylase recovery time,blood amylase recovery time,and ascites disappearance time between the two groups（ P〈0. 05）. Conclusion： Methyl prednisolone jointed with somatostatin in the treatment of severe acute pancreatitis can achieve good effect,greatly improving the prognosis of patients,and enhancing patients＇ quality of life.
出处
《包头医学院学报》
CAS
2017年第2期54-54,91,共2页
Journal of Baotou Medical College
关键词
甲泼尼龙
生长抑素
急性胰腺炎
Methyl prednisolone
Somatostatin
Acute pancreatitis
